# Breast Center

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/breast-center/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 3 |
| Citations | 286,743 |
| City | Zurich |
| Country | CH |
| Description | Breast Center is a research organisation in Zurich, CH. OpenAlex records 3,372 works and 286,743 citations for it. 1,130 researchers list it as their most recent affiliation. |
| Homepage | https://brust-zentrum.ch |
| OpenAlex ID | https://openalex.org/I4210121882 |
| Region | Zurich |
| Researchers | 1,130 |
| ROR ID | https://ror.org/02h67zw08 |
| Type | healthcare |
| Works | 3,372 |

## University papers

- [Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy](https://scholariq.org/papers/omission-of-axillary-dissection-following-nodal-downstaging-with-neoadjuvant/)
- [Breast-Conserving Therapy is Associated with Improved Survival Compared with Mastectomy for Early-Stage Breast Cancer: A Propensity Score Matched Comparison Using the National Cancer Database](https://scholariq.org/papers/breast-conserving-therapy-is-associated-with-improved-survival-compared-with/)
- [Risk factors for emergency caesarean section in planned vaginal breech delivery](https://scholariq.org/papers/risk-factors-for-emergency-caesarean-section-in-planned-vaginal-breech-delivery/)
- [Abstract GS4-02: Oncological Outcomes Following Omission of Axillary Lymph Node Dissection in Node Positive Patients Downstaging To Node Negative with Neoadjuvant Chemotherapy: the OPBC-04/EUBREAST-06/OMA study](https://scholariq.org/papers/abstract-gs4-02-oncological-outcomes-following-omission-of-axillary-lymph-node/)
- [Timing of mastectomy and the effect on the likelihood of outpatient surgery and cost savings in breast cancer patients](https://scholariq.org/papers/timing-of-mastectomy-and-the-effect-on-the-likelihood-of-outpatient-surgery-and/)
- [Impact of Neoadjuvant Versus Adjuvant Chemotherapy on the Extent of Axillary Surgery for Clinically Node-Negative Breast Cancers of Triple-Negative and HER2-Overexpressing Phenotypes](https://scholariq.org/papers/impact-of-neoadjuvant-versus-adjuvant-chemotherapy-on-the-extent-of-axillary/)
- [Abstract P2-09-15: Frequency of germline mutations in breast cancer susceptibility genes among women under age 50 presenting with parity associated breast cancer](https://scholariq.org/papers/abstract-p2-09-15-frequency-of-germline-mutations-in-breast-cancer/)
- [Neoadjuvant Chemotherapy Response and Genetic Susceptibility in Recently Parous Women with Breast Cancer: A Retrospective Analysis](https://scholariq.org/papers/neoadjuvant-chemotherapy-response-and-genetic-susceptibility-in-recently-parous-2/)
- [Gene methylation and cytological atypia in random fine needle aspirates for assessment of breast cancer risk: 10-year follow up in average risk women.](https://scholariq.org/papers/gene-methylation-and-cytological-atypia-in-random-fine-needle-aspirates-for/)
- [Neoadjuvant chemotherapy response and genetic susceptibility in recently parous women with breast cancer](https://scholariq.org/papers/neoadjuvant-chemotherapy-response-and-genetic-susceptibility-in-recently-parous/)
- [ASO Visual Abstract: Neoadjuvant Chemotherapy Response and Genetic Susceptibility in Recently Parous Women with Breast Cancer: A Retrospective Analysis](https://scholariq.org/papers/aso-visual-abstract-neoadjuvant-chemotherapy-response-and-genetic-susceptibility/)

## University researchers

- [Tamara K. Parissenti](https://scholariq.org/researchers/tamara-k-parissenti/)
- [Erica Wrubel](https://scholariq.org/researchers/erica-wrubel/)

## University top topics

Showing 8 of 25.

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)
- [Breast Implant and Reconstruction](https://scholariq.org/topics/breast-implant-and-reconstruction/)
- [Global Cancer Incidence and Screening](https://scholariq.org/topics/global-cancer-incidence-and-screening/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Reconstructive Surgery and Microvascular Techniques](https://scholariq.org/topics/reconstructive-surgery-and-microvascular-techniques/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.